Efficacy and safety of alemtuzumab after switching from a second line therapyA. Pato,D. M. Solar Sanchez,E. Costa,A. Lopez Real,E. Alvarez Rodriguez,V. Gonzalez Quintanilla,I. Gonzalez Suarez,L. Alvarez,J. R. Lorenzo, M. Arias Gomez, C. Lema Devesa,M. C. Amigo Jorrin,J. Pena MartinezMULTIPLE SCLEROSIS JOURNAL(2018)引用 1|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要